RNA interference and antiviral therapy
- PMID: 17876887
- PMCID: PMC4171298
- DOI: 10.3748/wjg.v13.i39.5169
RNA interference and antiviral therapy
Abstract
RNA interference (RNAi) is an evolutionally conserved gene silencing mechanism present in a variety of eukaryotic species. RNAi uses short double-stranded RNA (dsRNA) to trigger degradation or translation repression of homologous RNA targets in a sequence-specific manner. This system can be induced effectively in vitro and in vivo by direct application of small interfering RNAs (siRNAs), or by expression of short hairpin RNA (shRNA) with non-viral and viral vectors. To date, RNAi has been extensively used as a novel and effective tool for functional genomic studies, and has displayed great potential in treating human diseases, including human genetic and acquired disorders such as cancer and viral infections. In the present review, we focus on the recent development in the use of RNAi in the prevention and treatment of viral infections. The mechanisms, strategies, hurdles and prospects of employing RNAi in the pharmaceutical industry are also discussed.
Similar articles
-
RNA interference for antiviral therapy.J Gene Med. 2006 Aug;8(8):933-50. doi: 10.1002/jgm.929. J Gene Med. 2006. PMID: 16779870 Free PMC article. Review.
-
Application of RNA interference in treating human diseases.J Genet. 2010 Dec;89(4):527-37. doi: 10.1007/s12041-010-0073-3. J Genet. 2010. PMID: 21273705 Review.
-
The Nucleocapsid Protein of Coronaviruses Acts as a Viral Suppressor of RNA Silencing in Mammalian Cells.J Virol. 2015 Sep;89(17):9029-43. doi: 10.1128/JVI.01331-15. Epub 2015 Jun 17. J Virol. 2015. PMID: 26085159 Free PMC article.
-
RNA interference: its use as antiviral therapy.Handb Exp Pharmacol. 2006;173(173):117-50. doi: 10.1007/3-540-27262-3_7. Handb Exp Pharmacol. 2006. PMID: 16594614 Free PMC article. Review.
-
RNA interference: the molecular immune system.J Mol Histol. 2004 Aug;35(6):545-53. doi: 10.1007/s10735-004-2192-8. J Mol Histol. 2004. PMID: 15614608 Review.
Cited by
-
Focused role of nanoparticles against COVID-19: Diagnosis and treatment.Photodiagnosis Photodyn Ther. 2021 Jun;34:102287. doi: 10.1016/j.pdpdt.2021.102287. Epub 2021 Apr 6. Photodiagnosis Photodyn Ther. 2021. PMID: 33836276 Free PMC article. Review.
-
Short hairpin RNA targeting 2B gene of coxsackievirus B3 exhibits potential antiviral effects both in vitro and in vivo.BMC Infect Dis. 2012 Aug 6;12:177. doi: 10.1186/1471-2334-12-177. BMC Infect Dis. 2012. PMID: 22863145 Free PMC article.
-
Protection of mice against lethal rabies virus challenge using short interfering RNAs (siRNAs) delivered through lentiviral vector.Mol Biotechnol. 2014 Feb;56(2):91-101. doi: 10.1007/s12033-013-9685-1. Mol Biotechnol. 2014. PMID: 23877894 Free PMC article.
-
Inhibition of Junín virus replication by small interfering RNAs.Antiviral Res. 2009 Oct;84(1):31-7. doi: 10.1016/j.antiviral.2009.07.001. Epub 2009 Jul 8. Antiviral Res. 2009. PMID: 19591878 Free PMC article.
-
Dengue and Flavivirus Co-Infections: Challenges in Diagnosis, Treatment, and Disease Management.Int J Mol Sci. 2025 Jul 10;26(14):6609. doi: 10.3390/ijms26146609. Int J Mol Sci. 2025. PMID: 40724859 Free PMC article. Review.
References
-
- Hammond SM, Caudy AA, Hannon GJ. Post-transcriptional gene silencing by double-stranded RNA. Nat Rev Genet. 2001;2:110–119. - PubMed
-
- Olsen PH, Ambros V. The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol. 1999;216:671–680. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical